Anti-human FGF-21 Antibody, Rabbit pAb

Anti-human FGF-21 Antibody, Rabbit pAb

SKU: 11180

★ Download Datasheet PDF ★

 

Polyclonal Antibody against Human FGF-21

Application: ELISA

Size: 0.1 mg

Host: Rabbit

  • INTRODUCTION

    Fibroblast growth factor 21 (FGF-21) is a novel protein that has been implicated in the regulation of lipid and glucose metabolism under fasting and ketotic conditions [1,2]. In murine models, FGF-21 is predominantly expressed in liver, but also expressed in adipose tissue and pancreatic β-cells [3,4]. FGF-21 stimulates glucose uptake in adipocytes. It also protects animals from diet-induced obesity when overexpressed in transgenic mice and lowers blood glucose and triglyceride levels when administered to diabetic rodents [5]. When administered daily for 6 weeks to diabetic rhesus monkeys, FGF-21 caused a dramatic decline in fasting plasma glucose, fructosamine, triglycerides, insulin and glucagon [6]. Furthermore, elevated plasma FGF-21 concentrations in humans appear to be related to the presence of hepatic and peripheral insulin resistance [7].

  • IMMUNOGEN

    Recombinant full-length human FGF-21 expressed in E.coli.

  • SPECIFICITY

    The antibody detects circular human FGF-21.

  • FORMULATION

    Liquid in phosphate-buffered saline (PBS).

  • STORAGE

    Store at –20°C for less than one week. For long-term storage, aliquot and freeze at -70°C. Avoid repeated freeze/defrost cycles.

  • APPLICATION/ USAGE

    ELISA - The antibody can be used at 2 μg /mL with the appropriate secondary reagents to detect human FGF21.

  • PURIFICATION

    Antigen affinity-purified

  • REFERENCES

    [1] Kharitonenkov A, Shiyanova TL, et al. (2005) J Clin Invest; 115: 1627– 1635

    [2] Badman MK, Pissios P, et al. (2007) Cell Metab; 5: 426– 437

    [3] Nishimura T, Nakatake Y, et al. (2000) Biochim Biophys Acta; 1492: 203– 206

    [4] Kurosu H, Choi M, et al.  (2007) J Biol Chem; 282: 26687– 26695

    [5] Kharitonenkov A, Shiyanova TL, et al. (2005) J. Clin. Invest. 115: 1627–35.

    [6] Kharitonenkov A, Wroblewski VJ, et al. (2007) Endocrinology;148:774-81

    [7] Chavez AO, Molina-Carrion M, et al. (2009) Diabetes Care; 32:1542-6.

  • PUBLICATIONS CITING THIS PRODUCT

    1. Ye D, Li H, Wang Y, Jia W, Zhou J, Fan J, Man K, Lo C, Wong C, Wang Y, Lam KS. Circulating fibroblast growth factor 21 is a sensitive biomarker for severe ischemia/reperfusion injury in patients with liver transplantation. Scientific reports. 2016 Jan 25;6(1):1-9.
$240.00Price

For bulk order (QTY: 5 or more), please contact us for quote